TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

AFP

ELSA2-AFP
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
277.5

7
0 → 800 ng/ml

1

50μl
Serum, Plasma
amniotic fluid

2 x 30'
RT

5 weeks
(every 3 weeks)

Monoclonal antibodies

OCFA07-AFP
(100)

IRMA
Coated tubes

¹²⁵ I
300

5
0 → 800 UI/ml

2

50μl
Serum, Plasma
amniotic fluid 

2 x 15'
RT

8 weeks
(every 6 weeks)

Monoclonal antibodies

hCG FREE
β subunit

ELSA-FβHCG
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

6
0 → 50ng/ml

1

100μl
Serum, Plasma

1 h + 2 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies
Detects only
Free β chains

ELSA-FB150
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

6
0 → 150ng/ml

1

100μl
Serum, Plasma

2 x 1 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies
Detects only
Free β chains

CALCI
TONIN

ELSA-hCT
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
555

7
0 → 2250pg/ml

1

200μl
Pretreated serum

20 h
RT

3 weeks
(every 2 weeks)

Monoclonal antibodies

CATHEP
SIN-D

ELSA-CATH-D
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
296

5
0 → 4000 fmol/ml

2

Cytosol

3 h
RT

7 weeks
(every 4 weeks)

Monoclonal antibodies

CEA

ELSA2-CEA
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
296

6
0 → 200ng/ml

1

100μl
Serum, Plasma

3 h
45°C

6 weeks
(every 4 weeks)

Monoclonal antibodies

OCPP07-CEA
(100)

IRMA
Coated tubes

¹²⁵ I
170

7
0 → 20ng/ml

2

100μl
Serum, Plasma

1 h + 2 h
RT

9 weeks
(every 6 weeks)

Monoclonal antibodies

HTG

ELSA-HTG
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
222

7
0 → 50ng/ml

1

100μl
Serum, Plasma

3 h + 20 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

NSE

ELSA-NSE
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
370

6
0 → 200ng/ml

1

50μl
Serum

3 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

PAP

ELSA-PAP
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
370

6
0 → 50ng/ml

1

100μl
Serum

2 h
RT

4 weeks
(every 4 weeks)

Monoclonal antibodies

PSA

ELSA-PSA 2
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
370

7
0 → 120ng/ml

1

50μl
Serum, Plasma

2 h
45°C

5 weeks
(every 4 weeks)

Monoclonal antibodies
Ultrasensitivity

PSA-RIACT
(100)

IRMA
Coated tubes

¹²⁵ I
370

6
0 → 100ng/ml

1

50μl
Serum, Plasma

2 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies
Eqimolar assay

FREE PSA

FPSA-RIACT
(50)

IRMA
Coated tubes

¹²⁵ I
185

6
0 → 20ng/ml

1

100μl
Serum, Plasma

20 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies

PS2^TM

ELSA-PS2^TM
(96)

IRMA
ELSA Solid Phase

¹²⁵ I
370

6
0 → 2200 pol/ml

1

Cytosol

1 h
RT

4 weeks
(every 4 weeks)

Monoclonal antibodies

[1][2]